Development of a nursing intervention to facilitate optimal antiretroviral-treatment taking among people living with HIV

BMC Health Services Research

Volumn 9, Issue , 2009, Pages

  Ramirez Garcia, Pilar ^a   Côté, José ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; ATTITUDE TO ILLNESS; BEHAVIOR CHANGE; CASE REPORT; DOCTOR PATIENT RELATION; FOLLOW UP; HEALTH PROMOTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEEDS ASSESSMENT; NURSING INTERVENTION; PATIENT COMPLIANCE; PERSUASIVE COMMUNICATION; PREDICTOR VARIABLE; SELF CONCEPT; SIDE EFFECT; SOCIAL SUPPORT; VALIDATION PROCESS; FEMALE; MALE; METHODOLOGY; NURSING; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; THEORETICAL MODEL;

ANTI-RETROVIRAL AGENTS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MODELS, THEORETICAL; NEEDS ASSESSMENT; PATIENT COMPLIANCE; PRIMARY NURSING CARE; RESEARCH DESIGN; SELF EFFICACY;

EID: 68149114324     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-9-113     Document Type: Article

References (44)

1. Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. E Casalino M Wolff P Ravaud C Choquet F Bruneel B Regnier, AIDS 2004 18 1429 1433 10.1097/01.aids.0000131301. 55204.a7 15199319 (Pubitemid 38925135)
2. Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. RS Hogg BKC Yip KJP Craib MV O'Shaughnessy MT Schechter JSG Montaner, CMAJ 1999 160 5 659 665 10102000
3. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. JAC Sterne MA Hernan B Ledergerber K Tilling P Sendi M Rickenbach JM Robins M Egger tSHC Study, Lancet 2005 366 378 384 10.1016/S0140-6736(05)67022-5 16054937 (Pubitemid 41073955)
4. High levels of adherence do not prevent accumulation of HIV drug resistance mutations. DR Bangsberg ED Charlebois RM Grant M Holodniy SG Deeks S Perry KN Conroy R Clark D Guzman A Zolopa, AIDS 2003 17 1925 1932 10.1097/00002030-200309050-00011 12960825 (Pubitemid 37070278)
5. Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance. EM Gardner S Sharma P G K Huppler-Hullsiek WJ Burman RD MacArthur M Chesney EE Telzak G Friedland SB Mannheimer, AIDS 2008 22 75 82 18090394 10.1097/QAD.0b013e3282f366ff (Pubitemid 350294880)
6. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. D Paterson S Swindells J Mohr M Brester E Vergis C Squier MM Wagener N Singh, Ann Intern Med 2000 133 1 21 30 10877736
7. Persistent low-level viraemia and virological failure in HIV-1-infected patients treated with highly active antiretroviral therapy. S Sungkanuparph RK Groger ET Overton VJ Fraser WG Powderly, HIV Medicine 2006 7 437 441 10.1111/j.1468-1293.2006.00403.x 16925729 (Pubitemid 44269810)
8. Facteurs protecteurs et fragilisants de l'adhérence aux traitements des patients vivants avec le VIH: cas de la cohorte PROMOSUD [Protective and risk factors in treatment adherence by PLHIV: The case of the PROMOSUD cohort]. C Delpierre P Delmas S Delon, 74ème Congrès ACFAS Le savoir trame de la modernité: 1519 May 2006; Montréal 2006
9. Impact of discontinuation of initial protease inhibitor therapy on further virological response in a cohort of human immunodeficiency virus-infected patients. V LeMoing G Chne C Leport C Lewden S Duran M Garré B Masquelier M Dupon F Raffi group tACAs, Clin Infect Dis 2002 34 2 239 247 10.1086/324354 11740714 (Pubitemid 34028359)
10. Predictors of adherence to antiretroviral therapy: a one year longitudinal study. G Godin J Côté H Naccache LD Lambert S Trottier, AIDS Care 2005 17 493 504 16036235
11. Progress in HIV therapeutics and the challenges of adherence to antiretroviral therapy. L Andrews G Friedland, Infect Dis Clin North Am 2000 14 4 901 928 10.1016/S0891-5520(05)70139-2 11144644 (Pubitemid 32103895)
12. Patient adherence to HIV medication regimens: a review of published and abstract reports. L Fogarty D Roter S Larson J Burke J Gillespie R Levy, Patient Educ Couns 2002 46 2 93 108 10.1016/S0738-3991(01)00219-1 11867239
13. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. M Haddad C Inch RH Glazier AL Wilkins GB Urbshott A Bayoumi S Rourke, The Cochrane Database of Systematic Reviews 2000 4 10908497
14. Antiretroviral adherence interventions: a review of current literature and ongoing studies. JM Simoni PA Frick DW Pantalone BJ Turner, Topics in HIV medicine 2003 11 6 185 198 14724327
15. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. S Rueda LY Park-Wyllie AM Bayoumi AM Tynan TA Antoniou SB Rourke RH Glazier, Cochrane Database Syst Rev 2006 3 CD001442 16855968
16. LK Bartholomew GS Parcel G Kok NH Gottlieb, Intervention mapping: Designing theory- and evidence-based health promotion programs Mountain View, CA: Mayfield Publishing Co 2001
17. LK Bartholomew GS Parcel G Kok NH Gottlieb, Planning health promotion programs: An intervention mapping approach San Francisco: Jossey-Bass 2006
18. Actualités en épidémiologie sur le VIH/sida [HIV/AIDS EPI updates]. http://www.phac-aspc.gc.ca/publicat/epiu-aepi/epi-1205/ index-f.html
19. Programme de surveillance de l'infection par le virus de l'immunodéficiencia humaine (VIH) au Québec. Cas déclarés de janvier juin 2006 et cas cumulatifs d'avril 2002 juin 2006 [Program for monitoring HIV infection in Quebec: Declared cases from January to June 2006 and cumulative cases from April 2002 to June 2006]. http://www.inspq.qc.ca/publications/notice.asp?E=p&NumPublication=614
20. Factors affecting adherence to antiretroviral therapy in people living with HIV/AIDS. P Ramirez J Côté J Assoc Nurses AIDS Care 2003 14 4 37 45 10.1177/1055329003252424 (Pubitemid 38552995)
21. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. V Gordillo J del Amo V Soriano J Gonzalez-Lahoz, AIDS 1999 13 1763 1769 10.1097/00002030-199909100-00021 10509579 (Pubitemid 30015725)
22. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. B Spire S Duran M Souville C Leport F Raffi JP Moatti the APROCO cohort study group, Soc Sci Med 2002 54 1481 1496 10.1016/S0277-9536(01)00125-3 12061483 (Pubitemid 34309013)
23. Decisions to get HIV tested and to accept antiretroviral therapies among gay/bisexual men: Implications for secondary prevention efforts. R Stall C Hoff TJ Coates J Paul KA Phillips M Ekstrand S Kegeles J Catania D Daigle R Diaz, J Acquir Immune Defic Syndr Hum Retrovirol 1996 11 151 160 8556397
24. Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: Findings from the Healthy Living Project. MO Johnson SL Catz RH Remien MJ Rotheram-Borus SF Morin E Charlebois C Gore-Felton RB Goldsten H Wolfe M Lightfoot, AIDS Patient Care and STD's 2003 17 12 645 656 10.1089/108729103771928708 (Pubitemid 38031552)
25. Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. A Tuldra CR Fumaz MJ Ferrer R Bayés A Arno M Balagué A Bonjoch A Jou E Negredo R Parades, J Acquir Immune Defic Syndr 2000 25 221 228 10.1097/00042560-200011010-00003 11115952
26. Prospective study of predictors of adherence to combination antiretroviral medication. CE Golin H Liu RD Hays LG Miller CK Beck J Ickovics AH Kaplan NS Wenger, J Gen Intern Med 2002 17 756 765 12390551 10.1046/j.1525-1497.2002.11214.x (Pubitemid 35286241)
27. Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. S Duran B Spire F Raffi V Walter D Bouhour V Journot V Cailleton C Leport JP Moatti group tAcs, HIV Clinical Trials 2001 2 1 38 45 10.1310/R8M7-EQ0M-CNPW-39FC 11590513
28. Adherence, side effects and efficacy of Stavudine plus Lamivudine plus Nelfinavir in treatment-experienced HIV-infected patients. B Roca CJ Gomez A Arnedo, J Infect 2000 41 50 54 10.1053/jinf.2000.0678 10942640 (Pubitemid 30654748)
29. Relationships between perception of engagement with health care provider and demographic characteristics, health status and adherence to therapeutic regimen in persons with HIV/AIDS. S Bakken WL Holzemer MA Brown GM Powell-Cope JG Turner J Inouye KM Nokes I Corless, Aids Patient Care STDS 2000 14 4 189 197 10.1089/108729100317795 10806637 (Pubitemid 30225313)
30. A Bandura, Self-efficacy: The exercice of control New York: Freeman 1997
31. RE Petty JT Cacioppo, Communication and persuasion: Central and peripheral routes to attitude change New York: Springer-Verag 1986
32. Emotional factors in attitudes and persuasion. RE Petty LR Fabrigar DT Wegener, Handbook of affective sciences Oxford University Press, Davidson RJ, Scherer KR, Goldsmith HH, 2003 752 772
33. Attitudes and attitude change. RE Petty DT Wegener LR Fabrigar, Annu Rev Psychol 1997 48 609 647 10.1146/annurev.psych.48.1.609 9046570
34. Infection au VIH: Guide thérapeutique [HIV infection: A therapeutic guide]. http://www.jag.on.ca/hiv
35. Evaluation of a brief intervention based on social cognitive theory to develop problem-solving skills among sixth-grade children. M Shrama R Petosa CA Heaney, Health Educ Behav 1999 26 4 465 477 10.1177/109019819902600406 10435232
36. K Lorig JF Fries, The arthritis helpbook: a tested self-management program for coping with your arthritis Reading: Addison Wesley Publishing Company 3 1990
37. laboration et évaluation d'une intervention infirmière de renforcement du soutien social auprès d'aidantes de parents atteints de démence. R Bergeron, [Development and evaluation of a nursing intervention to reinforce social support for female family caregivers of a relative with dementia] Université de Montréal 1994
38. Optimizing support in the natural network. CE Cutrona V Cole, Social Support Measurement and Intervention Oxford: Oxford University Press, Cohen S, Underwood LG, Gottlieb BH, 2002 278 308
39. Social networks and social support. CA Heaney BA Israel, Health behavior and health education: Theory, research and practice San Francisco: Jossey Bass, Glanz K, Rimer BK, Lewis FM, 3 2002 185 209
40. JA DeVito G Chassé C Vezeau, La communication interpersonnelle [Interpersonal communication] Quebec: ERPI 2001
41. Efficacy of interventions in improving adherence to antiretroviral therapy. J Côté G Godin, Int J STD AIDS 2005 16 335 343 10.1258/0956462053888934 15949060 (Pubitemid 40704906)
42. A program of symptom management for improving quality of life and drug adherence. PY Chiou BI Kuo MB Lee YM Chen P Chuang PC Lin, J Adv Nurs 2006 55 2 169 179 10.1111/j.1365-2648.2006.03902.x 16866809 (Pubitemid 44049898)
43. Testing a nurse-tailored HIV medication adherence intervention. WL Holzemer S Bakken CJ Portillo R Grimes J Welch D Wantland JT Mullan, Nurs Res 2006 55 3 189 197 10.1097/00006199-200605000-00005 16708043 (Pubitemid 44503666)
44. Home visits to improve adherence to highly active antiretroviral therapy: a randomized controlled trial. BA Williams PK Fennie AC Bova DJ Burgess AK Danvers DK Dieckhaus, J Acquir Immune Defic Syndr 2006 42 3 314 321 10.1097/01.qai.0000221681.60187.88 16770291 (Pubitemid 44050009)